Overexpression of ERBB2/HER-2, belonging to the ERBB family of tyrosine kinase receptors, is of great clinical importance in breast cancer, where it is tackled by the monoclonal antibody trastuzumab [38]. The gene discussed is ERBB2; the disease is breast carcinoma.